Study on inflammatory bowel disease northkoreatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northkoreatimes.com Daily Mail and Mail on Sunday newspapers.
Novel method instructs immune cells to help repair damaged tissues in the intestine
A method that instructs immune system cells to help repair damaged tissues in the intestine has been developed by researchers at KU Leuven and Seoul National University. This opens the way for more effective treatment of inflammatory bowel disease, including ulcerative colitis and Crohn s disease. The study was carried out on humans and mice.
When functioning correctly, the immune system protects against harmful agents such as bacteria that get into the body. But in conditions such as inflammatory bowel disease (IBD), the immune system attacks the tissues that line the gut, forming ulcers and causing pain and discomfort. Nearly 3.9 million women and 3.0 million men are living with IBD worldwide, and the number of cases is rising.
Researchers have developed a method that instructs immune system cells to help repair damaged tissue in the intestine. The finding opens the way for more effective treatment of inflammatory bowel disease.
A new COVID-19 vaccine clinical trial is starting in Colorado.
Researchers at the University of Colorado School of Medicine and UCHealth on the CU Anschutz Medical Campus are recruiting potential study participants for the COVID-19 investigational vaccine clinical trial. This is the third COVID-19 vaccine trial underway at UCHealth locations.
The recruitment period will run about two months at UCHealth University of Colorado Hospital which is the only hospital in Colorado participating in this clinical trial.
The investigational vaccine, NVX-CoV2373, which contains a protein antigen and the companyâs Matrix-M adjuvant, is being evaluated in a phase 3 clinical trial sponsored by Novavax and supported by the National Institutes of Health.Â